Vor Biopharma, Inc. (VOR)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Vor Biopharma, Inc. (VOR)
Company Performance

Current Price

as of Oct 16, 2024

$0.68

P/E Ratio

N/A

Market Cap

$46.19M

Description

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerVOR
  • Price$0.6753+4.81%

Trading Information

  • Market Cap$46.19M
  • Float87.13%
  • Average Daily Volume (1m)578,398
  • Average Daily Volume (3m)863,320
  • EPS-$1.74

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$27.84M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$28.14M
  • EV$16.18M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.47
Documents